Feed ONCO
ON

Onconetix, Inc.

ONCO · NASDAQ

$0.68 +6.07% (+$0.04)
1M +4.13%
Market Cap $2.35M
P/E Ratio -
Div. Yield -
ROE 91.95%

Bulios Fair Price

$0.73

6.9% upside

Trenutna cena

$0.68

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica ONCO trenutno podcenjena glede na svojo tržno ceno. Kako deluje?

Odkleni pošteno ceno

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Piotroski F-Score Weak
1/9
Valuation
75 /100
Cheap
P/B 0.17x
P/S 3.63x
P/FFO N/A
Growth
0 /100
Declining
Book val. growth 11.03%
FCF growth N/A
EPS growth N/A
Profitability
20 /100
Weak
Op. margin 1,265.55%
Gross margin 80.40%
FCF margin 1,596.09%
Quality
0 /100
Poor
ROA 62.07%
ROIC 59.86%
Asset turnover 0.04x
Debt
69 /100
Low
Int. coverage -31.79x
Debt/Equity 0.01x
Current ratio 2.21x
Stability
1 /100
Unstable
Profitable years 0
Beta 2.68x
EPS volatility 4,170.70%

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o ONCO
Online

O podjetju

Onconetix, Inc. is a commercial stage biotechnology company, which engages in the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The company was founded in October 2018 and is headquartered in Cincinnati, OH.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Biotechnology

CEO

David Allan White

Employees

2

Headquarters

Cincinnati

Prihajajoči dogodki

12 NOV.

Earnings

Upcoming earnings report

50d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.